SOPH
SOPHiA GENETICS SA
Price Chart
Latest Quote
$5.46
+0.22 (+4.20%)
Current Price
| Previous Close | $5.24 |
| Open | $5.35 |
| Day High | $5.49 |
| Day Low | $5.18 |
| Volume | 444,035 |
Stock Information
| Shares Outstanding | 71.79M |
| Total Debt | $62.42M |
| Cash Equivalents | $65.39M |
| Revenue | $81.18M |
| Net Income | $-80.94M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $391.98M |
| EPS (TTM) | $-1.18 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $350.96M |
| Sales | $81.18M |
| Income | $-80.94M |
| Book/sh | $0.64 |
| Cash/sh | $0.91 |
| Employees | 415 |
Financial Ratios
| Quick Ratio | 1.71 |
| Current Ratio | 2.06 |
| Debt/Eq | 136.63 |
Returns & Margins
| ROA | -29.71% |
| ROE | -123.28% |
| Gross Margin | 67.28% |
| Operating Margin | -79.69% |
| Profit Margin | -99.70% |
Ownership
| Insider Ownership | 8.31% |
| Institutional Ownership | 55.97% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -9.75 |
| P/S | 4.83 |
| P/B | 8.58 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $8.00 |
Technical Indicators
| SMA20 | $5.07 |
| SMA50 | $5.01 |
| SMA200 | $4.66 |
| RSI | 59.53 |
| ATR | 0.3266 |
| Shares Float | 51.73M |
| Short Float | 0.42% |
| Short Ratio | 2.93 |
| Volatility | 0.98 |
| Rel Volume | 2.13 |
Performance History
| Week | +5.00% |
| Month | +16.67% |
| Quarter | +12.35% |
| 6 Months | +13.51% |
| YTD | +16.92% |
| Year | +86.99% |
| 3 Years | +35.82% |
| 10 Years | -67.42% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $5.46 | 445,100 |
| 2026-06-17 | $5.24 | 1,556,300 |
| 2026-06-16 | $4.93 | 196,900 |
| 2026-06-15 | $5.01 | 65,100 |
| 2026-06-12 | $4.88 | 95,000 |
| 2026-06-11 | $5.20 | 63,100 |
| 2026-06-10 | $5.22 | 158,300 |
| 2026-06-09 | $5.40 | 236,000 |
| 2026-06-08 | $5.28 | 605,800 |
| 2026-06-05 | $5.00 | 79,700 |
| 2026-06-04 | $4.96 | 140,000 |
| 2026-06-03 | $4.78 | 22,500 |
| 2026-06-02 | $4.94 | 42,400 |
| 2026-06-01 | $4.99 | 59,900 |
| 2026-05-29 | $5.05 | 52,800 |
| 2026-05-28 | $5.08 | 101,200 |
| 2026-05-27 | $5.08 | 38,100 |
| 2026-05-26 | $5.01 | 58,300 |
| 2026-05-22 | $4.88 | 100,700 |
| 2026-05-21 | $5.05 | 56,600 |
| 2026-05-20 | $4.87 | 57,000 |
| 2026-05-19 | $4.68 | 82,400 |
About SOPHiA GENETICS SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
đ° Latest News
Insider Spends US$99k Buying More Shares In SOPHiA GENETICS
Simply Wall St. âĸ 2026-06-07T13:47:12Z
Undervalued Opportunities: Top Penny Stocks To Watch In May 2026
Simply Wall St. âĸ 2026-05-21T12:05:10Z
SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-05T20:54:26Z
SOPHiA GENETICS Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-05T20:20:12Z
SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-05T20:03:12Z
BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8
Insider Monkey âĸ 2026-05-05T11:39:06Z
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?
Zacks âĸ 2026-04-27T12:20:00Z
How The SOPHiA GENETICS (NasdaqGS:SOPH) Narrative Is Shifting With New Fair Value Targets
Simply Wall St. âĸ 2026-04-26T18:03:24Z
What's Driving TEM Data and Applications Arm's Robust Growth?
Zacks âĸ 2026-04-07T18:24:00Z
How The SOPHiA GENETICS (SOPH) Narrative Is Shifting With Recalibrated Growth And Valuation Assumptions
Simply Wall St. âĸ 2026-03-27T18:08:17Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $18,279,000 | $15,751,000 | $14,865,000 | $16,306,000 |
| Cost Of Revenue | $25,194,000 | $21,236,000 | $19,458,000 | $16,306,000 |
| Total Revenue | $77,271,000 | $65,173,000 | $62,371,000 | $47,560,000 |
| Operating Revenue | $77,271,000 | $65,173,000 | $62,371,000 | $47,560,000 |
| Expenses | ||||
| Interest Expense | $4,554,000 | $1,913,000 | $588,000 | $639,000 |
| Total Expenses | $148,177,000 | $131,741,000 | $137,197,000 | $135,383,000 |
| Other Income Expense | $-3,899,000 | $3,849,000 | $-7,628,000 | $-447,000 |
| Net Non Operating Interest Income Expense | $-2,682,000 | $1,449,000 | $3,959,000 | $685,000 |
| Interest Expense Non Operating | $4,554,000 | $1,913,000 | $588,000 | $639,000 |
| Operating Expense | $122,983,000 | $110,505,000 | $117,739,000 | $119,077,000 |
| Other Operating Expenses | $86,000 | $-183,000 | $-954,000 | $-377,000 |
| Selling And Marketing Expense | $34,892,000 | $28,020,000 | $26,955,000 | $28,267,000 |
| General And Administrative Expense | $51,175,000 | $45,191,000 | $51,026,000 | $55,816,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-78,999,000 | $-62,493,000 | $-78,981,000 | $-87,449,000 |
| Net Interest Income | $-2,682,000 | $1,449,000 | $3,959,000 | $685,000 |
| Interest Income | $1,872,000 | $3,362,000 | $4,547,000 | $1,324,000 |
| Normalized Income | $-76,074,750 | $-65,379,750 | $-73,260,000 | $-87,002,694 |
| Net Income From Continuing And Discontinued Operation | $-78,999,000 | $-62,493,000 | $-78,981,000 | $-87,449,000 |
| Total Operating Income As Reported | $-70,906,000 | $-66,568,000 | $-74,826,000 | $-87,823,000 |
| Net Income Common Stockholders | $-78,999,000 | $-62,493,000 | $-78,981,000 | $-87,449,000 |
| Net Income | $-78,999,000 | $-62,493,000 | $-78,981,000 | $-87,449,000 |
| Net Income Including Noncontrolling Interests | $-78,999,000 | $-62,493,000 | $-78,981,000 | $-87,449,000 |
| Net Income Continuous Operations | $-78,999,000 | $-62,493,000 | $-78,981,000 | $-87,449,000 |
| Pretax Income | $-77,487,000 | $-61,270,000 | $-78,495,000 | $-87,585,000 |
| Interest Income Non Operating | $1,872,000 | $3,362,000 | $4,547,000 | $1,324,000 |
| Operating Income | $-70,906,000 | $-66,568,000 | $-74,826,000 | $-87,823,000 |
| Depreciation Amortization Depletion Income Statement | $2,614,000 | $3,111,000 | $3,743,000 | - |
| Depreciation And Amortization In Income Statement | $2,614,000 | $3,111,000 | $3,743,000 | - |
| Amortization Of Intangibles Income Statement | $287,000 | $497,000 | $729,000 | - |
| Depreciation Income Statement | $2,327,000 | $2,614,000 | $3,014,000 | - |
| Gross Profit | $52,077,000 | $43,937,000 | $42,913,000 | $31,254,000 |
| Per Share | ||||
| Diluted EPS | $-1.17 | $-0.95 | $-1.22 | $-1.36 |
| Basic EPS | $-1.17 | $-0.95 | $-1.22 | $-1.36 |
| Other | ||||
| Tax Effect Of Unusual Items | $-974,750 | $962,250 | $-1,907,000 | $-694 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-59,505,000 | $-54,610,000 | $-61,943,000 | $-80,928,000 |
| Total Unusual Items | $-3,899,000 | $3,849,000 | $-7,628,000 | $-447,000 |
| Total Unusual Items Excluding Goodwill | $-3,899,000 | $3,849,000 | $-7,628,000 | $-447,000 |
| Reconciled Depreciation | $9,529,000 | $8,596,000 | $8,336,000 | $5,571,000 |
| EBITDA (Bullshit earnings) | $-63,404,000 | $-50,761,000 | $-69,571,000 | $-81,375,000 |
| EBIT | $-72,933,000 | $-59,357,000 | $-77,907,000 | $-86,946,000 |
| Diluted Average Shares | $67,539,835 | $65,782,105 | $64,750,886 | $64,099,213 |
| Basic Average Shares | $67,539,835 | $65,782,105 | $64,750,886 | $64,099,213 |
| Diluted NI Availto Com Stockholders | $-78,999,000 | $-62,493,000 | $-78,981,000 | $-87,449,000 |
| Tax Provision | $1,512,000 | $1,223,000 | $486,000 | $-136,000 |
| Gain On Sale Of Security | $-3,899,000 | $3,849,000 | $-7,628,000 | $-447,000 |
| Amortization | $287,000 | $497,000 | $729,000 | - |
| Research And Development | $34,216,000 | $34,366,000 | $36,969,000 | $35,371,000 |
| Selling General And Administration | $86,067,000 | $73,211,000 | $77,981,000 | $84,083,000 |
| Other Gand A | $51,175,000 | $45,191,000 | $51,026,000 | $55,816,000 |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $11,254,000 | $67,492,000 | $124,257,000 | $180,167,000 |
| Total Assets | $163,031,000 | $155,309,000 | $206,156,000 | $243,838,000 |
| Total Non Current Assets | $63,952,000 | $55,904,000 | $58,109,000 | $47,583,000 |
| Non Current Prepaid Assets | $1,995,000 | $1,518,000 | $1,357,000 | $941,000 |
| Non Current Deferred Assets | $2,029,000 | $1,767,000 | $1,720,000 | $1,940,000 |
| Non Current Deferred Taxes Assets | $1,831,000 | $1,767,000 | $1,720,000 | $1,940,000 |
| Non Current Accounts Receivable | $4,013,000 | $4,244,000 | $4,743,000 | $3,342,000 |
| Goodwill And Other Intangible Assets | $35,891,000 | $28,998,000 | $27,185,000 | $19,963,000 |
| Other Intangible Assets | $26,335,000 | $20,656,000 | $18,186,000 | $11,775,000 |
| Current Assets | $99,079,000 | $99,405,000 | $148,047,000 | $196,255,000 |
| Other Current Assets | $758,000 | $835,000 | $345,000 | $731,000 |
| Current Deferred Assets | $2,002,000 | $0 | - | $0 |
| Prepaid Assets | $3,154,000 | $3,786,000 | $2,764,000 | $3,703,000 |
| Inventory | $6,351,000 | $5,868,000 | $6,482,000 | $5,156,000 |
| Receivables | $16,525,000 | $8,690,000 | $15,205,000 | $8,053,000 |
| Receivables Adjustments Allowances | $-366,000 | $-394,000 | $-1,181,000 | $-1,095,000 |
| Other Receivables | $1,102,000 | $742,000 | $4,644,000 | $1,844,000 |
| Taxes Receivable | $1,385,000 | $1,254,000 | $1,483,000 | $1,244,000 |
| Accounts Receivable | $14,404,000 | $7,088,000 | $10,259,000 | $6,060,000 |
| Cash Cash Equivalents And Short Term Investments | $70,289,000 | $80,226,000 | $123,251,000 | $178,612,000 |
| Cash And Cash Equivalents | $70,289,000 | $80,226,000 | $123,251,000 | $161,305,000 |
| Cash Equivalents | $32,830,000 | $66,443,000 | $107,183,000 | $135,485,000 |
| Cash Financial | $37,459,000 | $13,783,000 | $16,068,000 | $25,820,000 |
| Other Non Current Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $63,020,000 | $30,030,000 | $18,601,000 | $16,743,000 |
| Long Term Debt And Capital Lease Obligation | $60,320,000 | $27,840,000 | $15,673,000 | $14,053,000 |
| Long Term Debt | $47,733,000 | $13,237,000 | - | - |
| Current Debt And Capital Lease Obligation | $2,700,000 | $2,190,000 | $2,928,000 | $2,690,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $115,886,000 | $58,819,000 | $54,714,000 | $43,708,000 |
| Total Non Current Liabilities Net Minority Interest | $65,358,000 | $32,016,000 | $19,093,000 | $16,898,000 |
| Other Non Current Liabilities | $876,000 | $337,000 | $334,000 | $170,000 |
| Current Liabilities | $50,528,000 | $26,803,000 | $35,621,000 | $26,810,000 |
| Other Current Liabilities | $1,412,000 | $444,000 | - | - |
| Current Deferred Liabilities | $16,720,000 | $5,732,000 | $9,494,000 | $3,434,000 |
| Payables And Accrued Expenses | $13,843,000 | $7,656,000 | $9,621,000 | $10,418,000 |
| Payables | $8,960,000 | $5,220,000 | $5,391,000 | $6,181,000 |
| Other Payable | $2,840,000 | $2,630,000 | $2,366,000 | $3,655,000 |
| Total Tax Payable | $805,000 | $658,000 | $769,000 | $356,000 |
| Accounts Payable | $5,315,000 | $1,932,000 | $2,256,000 | $2,170,000 |
| Derivative Product Liabilities | - | - | - | - |
| Non Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $47,145,000 | $96,490,000 | $151,442,000 | $200,130,000 |
| Total Equity Gross Minority Interest | $47,145,000 | $96,490,000 | $151,442,000 | $200,130,000 |
| Stockholders Equity | $47,145,000 | $96,490,000 | $151,442,000 | $200,130,000 |
| Gains Losses Not Affecting Retained Earnings | $89,150,000 | $61,037,000 | $53,978,000 | $23,963,000 |
| Other Equity Adjustments | $89,150,000 | $61,037,000 | $53,978,000 | $23,963,000 |
| Retained Earnings | $-519,276,000 | $-440,277,000 | $-377,784,000 | $-298,803,000 |
| Long Term Equity Investment | $1,977,000 | $0 | - | - |
| Other | ||||
| Treasury Shares Number | $20,834,882 | $12,634,135 | $11,667,605 | $2,166,944 |
| Ordinary Shares Number | $68,486,338 | $66,687,085 | $65,230,559 | $64,231,220 |
| Share Issued | $89,321,220 | $79,321,220 | $76,898,164 | $66,398,164 |
| Tangible Book Value | $11,254,000 | $67,492,000 | $124,257,000 | $180,167,000 |
| Invested Capital | $94,878,000 | $109,727,000 | $151,442,000 | $200,130,000 |
| Working Capital | $48,551,000 | $72,602,000 | $112,426,000 | $169,445,000 |
| Capital Lease Obligations | $15,287,000 | $16,793,000 | $18,601,000 | $16,743,000 |
| Total Capitalization | $94,878,000 | $109,727,000 | $151,442,000 | $200,130,000 |
| Treasury Stock | $1,218,000 | $702,000 | $646,000 | $117,000 |
| Additional Paid In Capital | $473,675,000 | $472,244,000 | $471,846,000 | $471,623,000 |
| Capital Stock | $4,814,000 | $4,188,000 | $4,048,000 | $3,464,000 |
| Common Stock | $4,814,000 | $4,188,000 | $4,048,000 | $3,464,000 |
| Employee Benefits | $4,162,000 | $3,839,000 | $3,086,000 | $2,675,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $4,162,000 | $3,839,000 | $3,086,000 | $2,675,000 |
| Long Term Capital Lease Obligation | $12,587,000 | $14,603,000 | $15,673,000 | $14,053,000 |
| Current Deferred Revenue | $16,720,000 | $5,732,000 | $9,494,000 | $3,434,000 |
| Current Capital Lease Obligation | $2,700,000 | $2,190,000 | $2,928,000 | $2,690,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $15,853,000 | $10,781,000 | $13,578,000 | $10,268,000 |
| Current Accrued Expenses | $4,883,000 | $2,436,000 | $4,230,000 | $4,237,000 |
| Investments And Advances | $1,977,000 | $0 | - | - |
| Goodwill | $9,556,000 | $8,342,000 | $8,999,000 | $8,188,000 |
| Net PPE | $18,047,000 | $19,377,000 | $23,104,000 | $21,397,000 |
| Accumulated Depreciation | $-7,859,000 | $-5,713,000 | $-4,131,000 | $-3,420,000 |
| Gross PPE | $25,906,000 | $25,090,000 | $27,235,000 | $24,817,000 |
| Leases | $8,285,000 | $6,456,000 | $6,855,000 | $6,182,000 |
| Machinery Furniture Equipment | $5,239,000 | $4,466,000 | $4,745,000 | $4,367,000 |
| Buildings And Improvements | $12,382,000 | $14,168,000 | $15,635,000 | $14,268,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-1,443,000 | $-1,084,000 | $-2,134,000 | $-1,503,000 |
| Finished Goods | $204,000 | $105,000 | $127,000 | $124,000 |
| Work In Process | $2,047,000 | $1,321,000 | $1,482,000 | $1,340,000 |
| Raw Materials | $5,543,000 | $5,526,000 | $7,007,000 | $5,195,000 |
| Other Short Term Investments | - | - | $0 | $17,307,000 |
| Non Current Deferred Revenue | - | - | - | - |
| Long Term Provisions | - | - | - | - |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-44,513,000 | $-52,691,000 | $-62,450,000 | $-80,474,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-35,893,000 | $-44,515,000 | $-53,224,000 | $-70,093,000 |
| Cash Flow From Continuing Operating Activities | $-35,893,000 | $-44,515,000 | $-53,224,000 | $-70,093,000 |
| Operating Gains Losses | $497,000 | $-370,000 | $28,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-8,620,000 | $-8,176,000 | $-9,226,000 | $-10,381,000 |
| Investing Cash Flow | $-8,670,000 | $-4,755,000 | $12,975,000 | $41,973,000 |
| Cash Flow From Continuing Investing Activities | $-8,670,000 | $-4,755,000 | $12,975,000 | $41,973,000 |
| Capital Expenditure Reported | $-7,938,000 | $-7,737,000 | $-7,469,000 | $-5,820,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $1,093,000 | $0 | $0 | $0 |
| Financing Cash Flow | $30,177,000 | $9,857,000 | $-2,823,000 | $-1,568,000 |
| Cash Flow From Continuing Financing Activities | $30,177,000 | $9,857,000 | $-2,823,000 | $-1,568,000 |
| Cash Dividends Paid | $0 | $0 | $0 | - |
| Net Common Stock Issuance | $1,093,000 | $0 | $0 | $0 |
| Common Stock Issuance | $1,093,000 | $0 | $0 | $0 |
| Net Other Financing Charges | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-1,872,000 | $-2,750,000 | $-3,043,000 | $-2,316,000 |
| Issuance Of Debt | $34,563,000 | $13,930,000 | $0 | $0 |
| End Cash Position | $70,289,000 | $80,226,000 | $123,251,000 | $161,305,000 |
| Beginning Cash Position | $80,226,000 | $123,251,000 | $161,305,000 | $192,962,000 |
| Effect Of Exchange Rate Changes | $4,449,000 | $-3,612,000 | $5,018,000 | $-1,969,000 |
| Changes In Cash | $-14,386,000 | $-39,413,000 | $-43,072,000 | $-29,688,000 |
| Interest Paid Cff | $-3,953,000 | $-1,728,000 | $-6,000 | - |
| Proceeds From Stock Option Exercised | $346,000 | $405,000 | $226,000 | $748,000 |
| Net Issuance Payments Of Debt | $32,691,000 | $11,180,000 | $-3,043,000 | $-2,316,000 |
| Net Long Term Debt Issuance | $32,691,000 | $11,180,000 | $-3,043,000 | $-2,316,000 |
| Long Term Debt Payments | $-1,872,000 | $-2,750,000 | $-3,043,000 | $-2,316,000 |
| Long Term Debt Issuance | $34,563,000 | $13,930,000 | $0 | $0 |
| Interest Received Cfi | $1,835,000 | $3,421,000 | $4,655,000 | - |
| Net Investment Purchase And Sale | $0 | $0 | $17,546,000 | $52,354,000 |
| Sale Of Investment | $0 | $0 | $17,546,000 | $78,533,000 |
| Net Business Purchase And Sale | $-1,885,000 | $0 | $0 | - |
| Purchase Of Business | $-1,885,000 | $0 | $0 | - |
| Net Intangibles Purchase And Sale | $-108,000 | $-195,000 | $-263,000 | $-464,000 |
| Purchase Of Intangibles | $-108,000 | $-195,000 | $-263,000 | $-464,000 |
| Net PPE Purchase And Sale | $-574,000 | $-244,000 | $-1,494,000 | $-4,097,000 |
| Purchase Of PPE | $-574,000 | $-244,000 | $-1,494,000 | $-4,097,000 |
| Taxes Refund Paid | $-200,000 | $-536,000 | $-801,000 | $0 |
| Change In Working Capital | $10,707,000 | $-2,581,000 | $872,000 | $-1,273,000 |
| Change In Payables And Accrued Expense | $16,930,000 | $-7,385,000 | $6,871,000 | $-1,428,000 |
| Change In Payable | $16,930,000 | $-7,385,000 | $6,871,000 | $-1,428,000 |
| Change In Account Payable | $16,930,000 | $-7,385,000 | $6,871,000 | $-1,428,000 |
| Change In Prepaid Assets | $334,000 | $-1,157,000 | $1,375,000 | $-977,000 |
| Change In Inventory | $46,000 | $69,000 | $-874,000 | $-200,000 |
| Change In Receivables | $-6,603,000 | $5,892,000 | $-6,500,000 | $1,332,000 |
| Changes In Account Receivables | $-6,603,000 | $5,892,000 | $-6,500,000 | $1,332,000 |
| Other Non Cash Items | $5,127,000 | $-5,210,000 | $2,201,000 | $-685,000 |
| Stock Based Compensation | $16,205,000 | $16,488,000 | $15,242,000 | $13,613,000 |
| Provisionand Write Offof Assets | $706,000 | $1,094,000 | $522,000 | $486,000 |
| Deferred Tax | $-977,000 | $-726,000 | $-1,129,000 | $-1,292,000 |
| Deferred Income Tax | $-977,000 | $-726,000 | $-1,129,000 | $-1,292,000 |
| Depreciation Amortization Depletion | $9,529,000 | $8,596,000 | $8,336,000 | $5,571,000 |
| Depreciation And Amortization | $9,529,000 | $8,596,000 | $8,336,000 | $5,571,000 |
| Amortization Cash Flow | $5,553,000 | $4,021,000 | $2,828,000 | $1,780,000 |
| Amortization Of Intangibles | $5,553,000 | $4,021,000 | $2,828,000 | $1,780,000 |
| Depreciation | $3,976,000 | $4,575,000 | $5,508,000 | $3,791,000 |
| Gain Loss On Investment Securities | $497,000 | $-370,000 | - | - |
| Gain Loss On Sale Of PPE | $0 | $0 | $28,000 | $0 |
| Net Income From Continuing Operations | $-77,487,000 | $-61,270,000 | $-78,495,000 | $-87,585,000 |
| Purchase Of Investment | - | $0 | $0 | $-26,179,000 |
| Interest Received Cfo | - | $3,421,000 | $4,655,000 | $1,265,000 |
| Interest Paid Cfo | - | $-1,728,000 | $-6,000 | $-266,000 |
| Asset Impairment Charge | - | $0 | $0 | $73,000 |
Fetched: 2026-06-15